Vident Investment Advisory’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-55,483	Closed	-$671K	–	1266
2023 Q1	$671K	Sell	55,483 -2,031	-4%	-$24.6K	0.02%	669
2022 Q4	$757K	Buy	+57,514	New	+$757K	0.03%	562